ArticleJPGN reports2026

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease.

Smridhi Mahajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.